Read Time:5 Second
Shares of Trinity Biotech rallied after the company boosted the revenue outlook for its rapid HIV test.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0